Prescription Drug Abuse: An Annotated Bibliography of Policy, Epidemiology, and Social Stigma
Overview
This annotated bibliography examines prescription drug abuse through multiple scholarly lenses, including the effectiveness of prescription drug monitoring programs (PDMP), regional political and economic factors influencing opioid abuse, and public perception and stigmatization of prescription drug abuse disorder. The paper synthesizes current research to establish credible sources for understanding this complex public health issue.
What this annotated bibliography covers
- Introduction establishing importance of credible sources in prescription drug abuse research
- Article 1: Grecu et al. on PDMP effectiveness in reducing nonmedical prescription drug use
- Article 2: Wykoff and Egen on political and regional variations in opioid abuse epidemiology
- Article 3: Shupp et al. on symptom recognition and stigmatization patterns across demographics
Preview
Prescription Drug Abuse
Student's Name
Institutional Affiliation
Course Title
Professor's Name
Submission Date
Prescription Drug Abuse
Part I: Annotated Bibliography
Introduction
Research is an exciting section in academic work or scholarly work. It is often essential to use credible sources to be authentic and qualify as a source of information and resource for current and future use. Various opinions and results exist on prescription drug abuse, but we can only accept opinions and results accompanied by credible evidence to the claims. However, the sources' credibility is determined by further observing the book source, article, and the authors. The study on prescription drug abuse is only credible if credible information sources support it.
Article #1 Grecu, A. M., Dave, D. M., & Saffer, H. (2018). Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse. Journal of Policy Analysis and Management. doi:10.1002/pam.22098
This article researched and estimated the effects of prescription drug monitoring programs, PDMP, whose key mandate targets access to Rx drugs' nonmedical use. Grecu et al. (2018) based the study on the objective of drug abuse indicators prescribed by the substance abuse, treatment admissions, and the deaths linked to the Rx drug. The estimate did not show any tangible effect of implementing an operational PDMP. However, the study found that compulsory access provisions that raised the utilization rates of the PDMP by demanding providers to question the PDMP before prescribing a controlled drug showed a high relationship to the reduction in Rx drug abuse.